Guidance for Allergan Inc. (AGN)
| Period |
Range |
Estimate |
Revenue Range |
Revenue Estimate |
Target |
Details |
| 2011 |
$3.62 – $3.64 |
$3.64 |
$5.30B – 2.39B |
$5.42B |
= Maintained |
Details |
| 2011 |
$3.62 – $3.64 |
$3.64 |
$5.30B – 5.37B |
$5.42B |
= Maintained |
Details |
| 2011 |
$3.59 – $3.63 |
$3.64 |
$5.22B – 5.37B |
$5.31B |
 Raised |
Details |
| Q4 2011 |
$0.97 – $0.99 |
$1.01 |
$1.33B – 1.41B |
$1.41B |
= Maintained |
Details |
| Q3 2011 |
$0.88 – $0.90 |
$0.91 |
N/A |
N/A |
= Maintained |
Details |
| Q2 2011 |
$0.93 – $0.95 |
$0.92 |
N/A |
N/A |
= Maintained |
Details |
| 2011 |
$3.54 – $3.60 |
$3.63 |
$5.02B – 5.22B |
$5.20B |
= Maintained |
Details |
| Q1 2011 |
$0.71 – $0.73 |
$0.78 |
$1.17B – 1.22B |
$1.20B |
= Maintained |
Details |
